From: Late-onset cblC defect: clinical, biochemical and molecular analysis
VARIABLE VALUE | NORMAL OUTCOME (n = 30) | POOR OUTCOME (n = 46) | P VALUE |
---|---|---|---|
Age at onset (years) | 6.8(2–15) | 11(2-32.8) | 0.011 |
Time from onset to diagnosis (months) | 1(0.2–132) | 5(0.2–240) | 0.019 |
Initial symptoms | Â | Â | Â |
 Neuropsychiatric symptoms | 14(30.3) | 37(69.7) | 0.001 |
 Renal involvement | 11(68.8) | 5(31.2) | 0.016 |
 Cardiovascular disease | 4(66.7) | 2(33.3) | 0.205 |
 Metabolic crises | 1(33.3) | 2(66.7) | 1.000 |
Nucleotide variant | Â | Â | Â |
 c.482G > A | 10(27%) | 27(73%) | 0.031 |
 c.80 A > G | 12(66.7%) | 6(33.3%) | 0.034 |
 c.394 C > T | 2(25.0%) | 6(75.0%) | 0.275 |
 Others | 6(46.2%) | 7(53.8%) | 0.955 |